Brookside Capital
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio0 active
5Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
50Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#40
Raises, 12 months#88
Co-investors#27
Co-investors
- Biotechnology Value FundVenture capital4 shared
- Boxer CapitalVenture capital4 shared
- EcoR1 CapitalVenture capital4 shared
- Frazier Healthcare PartnersVenture capital3 shared
- Gurnet Point CapitalVenture capital3 shared
- Mission Bay CapitalVenture capital3 shared
- Omega FundsVenture capital3 shared
- Perceptive AdvisorsVenture capital3 shared
- The Column GroupVenture capital3 shared
- Apple Tree PartnersVenture capital2 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.